Speaker Profile
STEFAN N. LUKIANOV
Stefan N. Lukianov, MS, AM is the founder, president and CEO of Salve Therapeutics, a biotechnology startup in Los Angeles, CA building viral biologics using computational tools. He completed his undergraduate work at the University of Maine, earning dual bachelor’s degrees in biochemistry and molecular and cellular biology. He also has dual master’s degrees in virology and biochemistry from the University of Pittsburgh and Harvard University, respectively. Stefan’s publishing experience spans respected academic journals and the general audience science press, and he has spent ample time teaching and tutoring in STEM fields, granting him unique science communication skills that contribute to his businesses’ development.

Stefan N. Lukianov
December 15 2023
01 : 00 PM EST
60 Minutes
Computer-Aided Drug Design with AI Implications
Biologics are complex drugs composed of biological material. Most sophisticated among these are cell and gene therapies due to the challenging indications they target. Despite genetic engineering technology being available since the late 1970s, this field has seen limited therapeutic development, with around a dozen FDA-approved gene therapies on the market. Most of these have been researched and developed ..

Stefan N. Lukianov
January 11 2024
01 : 00 PM EST
60 Minutes
Finding the Right Indication to Target First
There are many diseases demanding solutions that are best developed by startups. Startups are agile, quick, innovative, and demanding enterprises that are creative enough to research and develop these solutions without revenue. Does the startup form and then select a disease or does the startup form around a disease? Both are natural births for these exciting companies and can lead to life-changing solution..